D. CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY FOR 2017 AND 2016
(Millions of euros) |
SHARE |
SHARE |
MERGER PREMIUM |
TREASURY SHARES |
OTHER EQUITY INSTRUMENTS |
VALUATION ADJUSTMENTS |
RETAINED EARNINGS AND OTHER RESERVES |
ATTRIBUTABLE TO THE SHAREHOLDERS |
ATTRIBUTABLE TO NON- |
TOTAL EQUITY |
Balance at 31/12/16 |
147 |
1,202 |
650 |
-41 |
0 |
-1,092 |
4,731 |
5,597 |
717 |
6,314 |
Impact of transition to IFRS 15 (Note 1.3.1) |
0 |
0 |
0 |
0 |
0 |
0 |
-272 |
-272 |
0 |
-272 |
Balance at 01/01/17 |
147 |
1 202 |
650 |
-41 |
0 |
-1,092 |
4 459 |
5,325 |
717 |
6,042 |
Consolidated profit for the year |
|
|
|
|
|
|
454 |
454 |
53 |
507 |
Income and expense recognised directly in equity |
|
|
|
|
|
-185 |
|
-185 |
-60 |
-245 |
Total comprehensive income |
0 |
0 |
0 |
0 |
0 |
-185 |
454 |
269 |
-7 |
262 |
Scrip dividend |
3 |
|
|
|
|
|
-222 |
-218 |
|
-218 |
Other dividends |
|
|
|
|
|
|
|
0 |
-47 |
-47 |
Treasury share transactions |
-3 |
|
-298 |
1 |
|
|
-1 |
-302 |
0 |
-302 |
Remuneration of shareholders |
0 |
0 |
-301 |
1 |
0 |
0 |
-223 |
-520 |
-47 |
-568 |
Capital increases/reductions |
|
|
|
|
|
|
|
0 |
33 |
33 |
Share-based payment |
|
|
|
|
|
|
1 |
1 |
0 |
1 |
Other changes |
|
|
-2 |
-2 |
|
|
6 |
1 |
3 |
4 |
Other transactions |
0 |
0 |
-2 |
-2 |
0 |
0 |
7 |
2 |
35 |
38 |
Perpetual subordinated bond issues |
0 |
0 |
0 |
0 |
500 |
0 |
-5 |
495 |
0 |
495 |
Changes in the scope of consolidation |
0 |
0 |
0 |
0 |
0 |
0 |
-68 |
-68 |
33 |
-35 |
Balance at 31/12/17 |
146 |
1,202 |
349 |
-42 |
500 |
-1,277 |
4,624 |
5,503 |
731 |
6,234 |
(Millions of euros) |
SHARE |
SHARE |
MERGER PREMIUM |
TREASURY SHARES |
VALUATION ADJUSTMENTS |
RETAINED EARNINGS AND OTHER RESERVES |
ATTRIBUTABLE TO THE SHAREHOLDERS |
ATTRIBUTABLE TO NON- |
TOTAL EQUITY |
Balance at 31/12/15 |
146 |
1,202 |
963 |
-16 |
-805 |
4,567 |
6,058 |
483 |
6,541 |
Consolidated profit for the year |
|
|
|
|
|
376 |
376 |
7 |
383 |
Income and expense recognised directly in equity |
|
|
|
|
-287 |
|
-287 |
-8 |
-295 |
Total comprehensive income |
0 |
0 |
0 |
0 |
-287 |
376 |
89 |
-1 |
88 |
Scrip dividend |
3 |
|
|
|
|
-230 |
-226 |
|
-226 |
Other dividends |
|
|
|
|
|
|
0 |
-25 |
-25 |
Treasury share transactions |
-3 |
|
-313 |
-26 |
|
25 |
-317 |
|
-317 |
Remuneration of shareholders |
0 |
0 |
-313 |
-26 |
0 |
-205 |
-544 |
-25 |
-569 |
Capital increases/reductions |
|
|
|
|
|
|
0 |
45 |
45 |
Share-based payment |
|
|
|
|
|
-17 |
-17 |
0 |
-17 |
Other changes |
|
|
0 |
1 |
|
9 |
10 |
215 |
225 |
Other transactions |
0 |
0 |
0 |
1 |
0 |
-8 |
-7 |
260 |
253 |
Balance at 31/12/16 |
147 |
1,202 |
650 |
-41 |
-1,092 |
4,731 |
5,597 |
717 |
6,314 |
The accompanying Notes 1.1 to 7.1 are an integral part of the consolidated statement of changes in equity for the year ended 31 December 2017.
Translation of consolidated financial statements originally issued in Spanish and prepared in accordance with the regulatory financial reporting framework applicable to the Group in Spain (see Notes 1.1 and 7.1). In the event of a discrepancy, the Spanish-language version prevails.